- Home
- ETG vs CERT Comparison
ETG vs CERT Comparison
Compare ETG & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETG
- CERT
- Stock Information
- Founded
- ETG 2003
- CERT 2008
- Country
- ETG United States
- CERT United States
- Employees
- ETG N/A
- CERT N/A
- Industry
- ETG Investment Managers
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ETG Finance
- CERT Technology
- Exchange
- ETG Nasdaq
- CERT Nasdaq
- Market Cap
- ETG 1.6B
- CERT 1.7B
- IPO Year
- ETG N/A
- CERT 2020
- Fundamental
- Price
- ETG $21.18
- CERT $11.28
- Analyst Decision
- ETG
- CERT Buy
- Analyst Count
- ETG 0
- CERT 7
- Target Price
- ETG N/A
- CERT $15.00
- AVG Volume (30 Days)
- ETG 132.1K
- CERT 1.4M
- Earning Date
- ETG 01-01-0001
- CERT 11-05-2025
- Dividend Yield
- ETG 6.64%
- CERT N/A
- EPS Growth
- ETG N/A
- CERT N/A
- EPS
- ETG N/A
- CERT 0.05
- Revenue
- ETG N/A
- CERT $405,755,000.00
- Revenue This Year
- ETG N/A
- CERT $12.38
- Revenue Next Year
- ETG N/A
- CERT $7.49
- P/E Ratio
- ETG N/A
- CERT $227.36
- Revenue Growth
- ETG N/A
- CERT 11.61
- 52 Week Low
- ETG $14.08
- CERT $8.64
- 52 Week High
- ETG $18.34
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- ETG 63.16
- CERT 56.35
- Support Level
- ETG $20.50
- CERT $10.23
- Resistance Level
- ETG $21.08
- CERT $11.09
- Average True Range (ATR)
- ETG 0.19
- CERT 0.41
- MACD
- ETG 0.05
- CERT 0.03
- Stochastic Oscillator
- ETG 91.22
- CERT 88.33
About ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest
Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.